A randomized phase II study of comparing every 3 months- or six months-screening examination for the diagnosis of pancreatic cancer

A randomized phase II study of comparing every 3 months- or six months-screening examination for the diagnosis of pancreatic cancer - RCT for screening of PC

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005043

Enrollment

1000

Registered

2011-02-07

Start date

2010-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with main pancreatic duct dilatation and/or pancreatic cyst

Interventions

every three months examination every six months examination

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients of age =>35 and 75> Written informed consent.

Exclusion criteria

Exclusion criteria: Performance Status=<2 poor study of US Patients with active synchronous or metachronous malignancy drug allergy of iodine Patients with kidney damage Patients who are pregnant or have an intention to get pregnant

Design outcomes

Primary

Measure	Time frame
early pancreatic cancer rate	—

Countries

Japan

Contacts

Public ContactTatsuya Ioka

Osaka Medical Center fo Cancer and CVD Division of Hepatobiliary and Pancreatic Oncology

ioka_ta@hotmail.com06-6945-1181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026